0
ARTICLE |

Effect of Sabin Poliovirus Vaccine on Incidence of Poliomyelitis in Italy

A. Giovanardi, MD
JAMA. 1969;209(4):525-528. doi:10.1001/jama.1969.03160170021004.
Text Size: A A A
Published online

Extensive use of poliomyelitis vaccine (Salk) from 1958 to 1963 did not prevent the annual occurrence of thousands of paralytic cases of poliomyelitis in Italy. After the mass use of live oral poliovirus vaccine (Sabin) early in 1964, the number of reported cases quickly dropped from an average of more than 3,000/year during the four years prior to the use of oral vaccine to 254 in 1965, 147 in 1966, 106 in 1967, and 87 in 1968, and at least a portion of the reported cases could not be confirmed as having been caused by polioviruses. Most of the remaining cases of poliomyelitis have occurred in the southern and island regions (1.17/100,000 vs 0.08 in northern and 0.009 in central Italy in 1965; 0.68/100,000 vs 0.04 in northern, and 0.06 in central Italy in 1966) where the percentage of children vaccinated during the initial campaign and in the ongoing programs was, until recent compulsory vaccination legislation, much less than in the northern and central regions of the country.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs